In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...
In conclusion, the Easyhaler ® more closely demonstrates the characteristics of an ‘ideal inhaler' than its competitors (consistent fine particle dose, performance regardless of inspiration rate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback